Supplementary table 1. Supplementary table 2 Supplementary table 3.

Slides:

Advertisements

Similar presentations

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Advertisements

Slide 1Fig. 2.1a, p.25. Slide 2Fig. 2.1b, p.25 Slide 3Table 2.1, p.25.

Jungwirth et al. Suppl. Fig. 1 A B. Jungwirth et al. Suppl. Fig. 2 HCT-116  -actin Bim EL Bak Bax - + KP46 A A C KP46 (µM) hours.

Apaf-1 Caspase-9 Cyt c control sulindac control E LY control TRAIL thapsigargin HT-29Chondrocyte control SIN-1 RAW IP: AChE C Supplementary.

AB 11 22 33 44 55 66 77 88 99 10  20  19  18  17  16  15  14  13  12  11  21  22  23  24  25  26  27  28.

Slide 1Fig. 22.1, p.669. Slide 2Fig. 22.3, p.670.

Slide 1Fig. 17.1, p.513. Slide 2Table 17.1, p.514.

Fig. 16-CO, p Fig. 16-1, p. 450 Fig. 16-2, p. 450.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

1 times table 2 times table 3 times table 4 times table 5 times table

A prognostic model for lymph node negative breast cancer patients by Integrating proliferation and immune response Supplementary figures.

Supplementary Data Nonerythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage Pan Zhang, Utz Herbig, Frederick Coffman.

Mandal CC et al Supplementary Fig. S1. Increased expression of CSF-1 in human breast cancer cells. (A) The conditioned media from normal human breast epithelial.

PrimerSequence (5' to 3')Comments Hpt-FwCGCGACGTCTGTCGAGAAGTTT RT-PCR analysis Hpt-RvATCGGACGATTGCGTCGCATCGA RT-PCR analysis AOX1a-FwGATGTTTGTCTACTGCCGAGGATTT.

Table S1. Primers for quantitative RT-PCR β-actinSense5'-ATCTGGCACCACACCTTC-3' Antisense5'-AGCCAGGTCCAGACGCA-3' CD36Sense5'-TGGTCAAGCCAGCTAGAAA-3' Antisense5'-CCCAGTCTCATTTAGCCAC-3'

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Tables Learning Support

Supplementary Fig. 1. RT-PCR showed that tumor tissues have elevated Mst1 mRNA levels in most of the HCC patients tested. GAPDH RT-PCR products were shown.

B16 4T1 CT26 FL 72kD Cleaved 45kD (a) (b) Supplemenatry fig. 1 Full length (FL) and cleaved DR6 expression in B16, 4T1 and CT26 cells.

Fig. 6-CO, p p. 185a p. 185b p. 185c p. 185d.

Invest. Ophthalmol. Vis. Sci ;52(8): doi: /iovs Figure Legend:

A. BCL6 Intensity Score Bin B. CD7 Intensity Score Bin C.

تصنيف التفاعلات الكيميائية

DHEA(S) and Allo induced the expression of the antiapoptotic Bcl-2 proteins in serum-deprived PC12 cells. DHEA(S) and Allo induced the expression of the.

A B C D E F Supplementary Fig. 1. Gating strategy for CD44+CD133+CD24+ B16 tumor initiating cells (TIC). Cells were gated on CD44. CD44 positive cells.

A B C D E F Supplementary Fig. 2. Gating strategy for CD44+CD24+ ID8agg tumor initiating cells (TIC). Cells were gated on CD44. CD44 positive cells were.

Morphogens: Precise Outputs from a Variable Gradient

Relative expression ratio Relative expression ratio

Days after cell inoculation Days after cell inoculation

Days after cell inoculation Days after cell inoculation

Recurrence-free survival

SP1 was a downstream target of miR-150-3p

Supplementary Figure S1: FGFR4 silencing synergistically enhances the effects of chemotherapy in colon cancer cells. siFGFR4 FGFR4_6 FGFR4_2 Neg Con FGFR4.

GEOMETRICAL CONCEPTS LINE SEGMENT

Relative protein levels

Volume 149, Issue 4, Pages (May 2012)

Downregulation of human SSU72 results in telomere elongation and fragility Downregulation of human SSU72 results in telomere elongation and fragility Telomere.

Fig. 6-CO, p. 211.

Supplementary Figure S1

Anti-tumor effect of anti-PD-1 antibody against SCC3 tumor

Supplementary Fig. S1 BCL2 5’flanking ctrl siRNA luc

N H N H Figure S1 parp-1 +/+ parp-1 -/- HIF-2 DAPI

3 times tables.

Mutant Alanine Position

6 times tables.

Right Triangles with an altitude drawn.

Map-based cloning of ASI4 gene

Blocking actin turnover affects AJ remodeling and E-cad dynamics.

A B Supplementary Figure 1 (NEW). Muscle Liver p<0.05

Late gestational SF exposures alter miR-103/107 expression profiles and their target protein Cav1 in VWAT of offspring mice. Late gestational SF exposures.

miR-145 regulates IGF1R expression.

Targeting eIF4E increases ZEB1 protein and mRNA levels and decreases ZEB1-targeting miR-200c and miR-141 microRNAs. Targeting eIF4E increases ZEB1 protein.

Fig. 4. Effects of natriuretic peptide receptor 2 (NPR2) knockdown on cells apoptosis in mouse Leydig cells. (A) Relative mRNA expression of cell apoptosis.

Expression pattern of TLR-4 and MyD88 in EOC cells.

Dysregulated NF-κB activation in Il1r8+/+/lpr and Il1r8−/−/lpr mice.

Bortezomib induces an NRF2 signature and NRF2 protein in tumor cells from leukemic MCL. Gene sets regulated by bortezomib (Supplementary Tables S3 and.

BCL-2 and BCL-XL expression alters with maturation stage of the T cell

Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.

Expression of chemokine receptors in A-498 cell line.

IL2Cx alone or in combination with anti–CTLA-4 increases the CD8/Treg ratio in the tumor. IL2Cx alone or in combination with anti–CTLA-4 increases the.

mRNA expression of PARP1 in SCLC cell lines and solid tumors.

by Omesha N. Perera, Alexander P. Sobinoff, Erdahl T

Fig. 5 hTERT promotion of Hsp70-1 telomere localization is dependent on Apollo and assists the telomere protective function of Apollo. hTERT promotion.

6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti- androgen Receptor Therapy in Prostate Cancer Cells Xiaowei Zhang, Daniela.

Presentation transcript:

Supplementary table 1

Supplementary table 2

Supplementary table 3

Supplementary table 4 A. B.

VALIDATED hsa-miR-155 TARGETS AGTR1 AICDA BCL2 CSF1R CTLA4 CUX1 ETS1 FGF7 IKBKE IL13RA1 INPP5D IRAK3 JARID2 MYD88 RIPK1 RNF123 SKI SLA SOCS1 SPI1 WEE1 Supplementary table 5

Supplementary table 6

Supplementary Fig. S1 A.B.C.

Flag-TRF1 actin MG132 siTRF control miR  g WB  -TRF1 MG132 siTRF control miR-155 Flag-TRF1 end. TRF1 actin 20  g WB  -TRF end. TRF1/actin * B. C. A. TRF1 mRNA levels normalized to actin (con.miRNA set “1”) n=3 p=0.3 p=0.2 p=0.012 Supplementary Fig. S2 Flag-TRF1/actin

Supplementary Fig. S3 miR-155 signature low: n=593 miR-155 signature high: n=606 ER positive tumors

Supplementary Fig. S4 B.A. miR-155 a-miR-155 control TRF1 fluorescence intensity (a.f.u) 1312 ±30.52 n=602 N= ±31.08 n=512 N= ±37.79 n=508 N= 31 p< control miR-155 antago- miR-155 TRF1TRF1/DAPI antago- miR-155 MBA-MD-468 U 2-OS D. C. miR-155 a-miR-155 control POT1 fluorescence intensity (a.f.u) 1199 ±101.7 n=1199 N=35 p=0.119 p= ±86.24 n=1552 N= ±101.4 n=985 N= 30 control miR-155 antago- miR-155 POT1POT1/DAPI miR-155 a-miR-155 control TRF2 fluorescence intensity (a.f.u) ±54.45 n=1173 N=48 p=0.4 p= ±41.40 n=1267 N= ±51.07 n=1050 N= 48 control miR-155 antago- miR-155 TRF2TRF2/DAPI

TRF2 mRNA levels normalized versus actin n=3 p=0.2 TRF1 mRNA levels normalized versus actin n=3 p=0.2 miR-155 levels normalized versus RNU46 n=3 p< control miR-155 TRF1 protein levels normalized versus actin n=3 p=0.01 A.B. D. C. E. TRF1 actin Supplementary Fig. S5 telomere length (a.f.u.) A B C 1591 ± N=42 n= ± N=39 n=3521 p<0, control miR-155 telomere a.f.u intesisty categories (%)

p=0.035 N=3 n=50 N=3 n=50 TIF frequency (2< TIFs; %) miR-155 levels, normlized to RNU46 (con set “1”) control miR-155 control miR-155 TRF1 actin TIF frequency 3< TIFs; %) p=0.05 N=3 n=81 N=3 n=93 Supplementary Fig. S6 A. B.C.D.

n=1370 n=1533 N=17 N=20 p= 0,03 fragile telomeres (%) Supplementary Fig. S7 A. N=40 n=3084 N=40 n=3098 p=0,003 fragile telomeres (%) B. C.D. N=25 n=1974 N=25 n=1906 p= 0,04 fragile telomeres (%) Aphidicolin con.miRNA antago-miR Aphidicolin con.miRNA p=0.05 N=26 n=2134 N=21 N=1542 telomeric sister chromatid fusions (%)